|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-05-22 Sale |
2009-05-26 4:56 pm | ARYx Therapeutics, Inc. | ARYX | ORBIMED ADVISORS LLC ISALY SAMUEL D (10% owner) | 2,000,000 | $4 | $8,000,000 | 1,340,139 (Indirect) |
View |
| 2008-11-14 Purchase |
2008-11-18 4:39 pm |
ARYx Therapeutics, Inc. | ARYX | Adelman Robert J (Director 10% owner) | 1,214,646 | $0 | $0 | 3,340,139 (Indirect) |
View |
| 2008-11-14 Purchase | 2008-11-18 3:10 pm | ARYx Therapeutics, Inc. | ARYX | ORBIMED ADVISORS LLC ISALY SAMUEL D (10% owner) | 1,214,646 | $0 | $0 | 3,340,139 (Indirect) |
View |
| 2008-11-14 Purchase |
2008-11-17 7:23 pm | ARYx Therapeutics, Inc. | ARYX | MPM BIOVENTURES III QP LP MPM BIOVENTURES III PARALLEL FUND, LP MPM BIOVENTURES III GMBH & CO. Beteiligungs KG MPM BIOVENTURES III LP MPM BIOVENTURES III GP LP MPM BIOVENTURES III LLC MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC MPM BioVentures Strategic Fund LP (10% owner) | 1,787,710 | $2.2 | $3,932,962 | 5,364,572 (Indirect) | View |
| 2008-11-14 Purchase |
2008-11-17 7:18 pm |
ARYx Therapeutics, Inc. | ARYX | SIMON NICHOLAS J III (Director 10% owner) | 1,787,710 | $2.2 | $3,932,962 | 5,364,572 (Indirect) |
View |
| 2008-11-14 Purchase | 2008-11-17 7:15 pm |
ARYx Therapeutics, Inc. | ARYX | EVNIN LUKE GALAKATOS NICHOLAS HENNER DENNIS STEINMETZ MICHAEL GADICKE ANSBERT WHEELER KURT (10% owner) | 1,787,710 | $2.2 | $3,932,962 | 5,364,572 (Indirect) | View |
| 2007-11-13 Purchase | 2007-11-15 3:56 pm |
ARYx Therapeutics, Inc. | ARYX | ORBIMED ADVISORS LLC ISALY SAMUEL D (Director) | 300,000 | $10 | $3,000,000 | 2,125,493 (Indirect) |
View |
| 2007-11-13 Purchase | 2007-11-14 6:07 pm | ARYx Therapeutics, Inc. | ARYX | Adelman Robert J (Director 10% owner) | 300,000 | $10 | $3,000,000 | 300,000 (Indirect) |
View |
| 2007-11-13 Purchase |
2007-11-13 1:38 pm | ARYx Therapeutics, Inc. | ARYX | SIMON NICHOLAS J III (Director 10% owner) | 300,000 | $10 | $3,000,000 | 3,576,862 (Indirect) | View |
| 2007-11-13 Purchase |
2007-11-13 1:37 pm |
ARYx Therapeutics, Inc. | ARYX | EVNIN LUKE GALAKATOS NICHOLAS HENNER DENNIS STEINMETZ MICHAEL GADICKE ANSBERT WHEELER KURT (10% owner) | 300,000 | $10 | $3,000,000 | 3,576,862 (Indirect) |
View |
| 2007-11-13 Purchase | 2007-11-13 1:37 pm |
ARYx Therapeutics, Inc. | ARYX | MPM BIOVENTURES III QP LP MPM BIOVENTURES III PARALLEL FUND, LP MPM BIOVENTURES III GMBH & CO. Beteiligungs KG MPM BIOVENTURES III LP MPM BIOVENTURES III GP LP MPM BIOVENTURES III LLC MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC MPM BioVentures Strategic Fund LP (10% owner) | 300,000 | $10 | $3,000,000 | 3,576,862 (Indirect) | View |
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount | Shares Ownership |
Filing |
| 2009-08-17 Other |
2009-08-19 8:34 pm | ARYx Therapeutics, Inc. | ARYX | Druzgala Pascal (Sr. V.P. & Chief Scien.Off.) | 17,964 | $0 | $0 | 0 (Indirect) |
View |
| 2008-10-27 Other |
2008-10-28 8:43 pm |
ARYx Therapeutics, Inc. | ARYX | Druzgala Pascal (V.P. & Chief Scientific Off.) | 15,368 | $0 | $0 | 8,982 (Indirect) |
View |
| 2007-11-13 Purchase | 2007-11-15 3:56 pm |
ARYx Therapeutics, Inc. | ARYX | ORBIMED ADVISORS LLC ISALY SAMUEL D (Director) | 1,825,493 | $0 | $0 | 1,825,493 (Indirect) | View |
| 2007-11-13 Purchase |
2007-11-14 6:10 pm | ARYx Therapeutics, Inc. | ARYX | Milner Peter G (Pres., Research & Dev. Director) | 47,739 | $0 | $0 | 31,903 (Direct Indirect) | View |
| 2007-11-13 Purchase | 2007-11-14 6:09 pm | ARYx Therapeutics, Inc. | ARYX | GODDARD PAUL (Chairman & CEO Director) | 3,021 | $0 | $0 | 57,187 (Indirect) | View |
| 2007-11-13 Purchase |
2007-11-14 6:07 pm | ARYx Therapeutics, Inc. | ARYX | Adelman Robert J (Director 10% owner) | 1,825,493 | $0 | $0 | 2,125,493 (Indirect) | View |
| 2007-11-13 Purchase |
2007-11-14 6:05 pm | ARYx Therapeutics, Inc. | ARYX | Druzgala Pascal (V.P. & Chief Scientific Off.) | 1,122 | $0 | $0 | 205,288 (Direct) |
View |
| 2007-11-13 Purchase | 2007-11-13 6:59 pm | ARYx Therapeutics, Inc. | ARYX | Nomura Phase4 Ventures LTD Nomura Phase4 Ventures LP (10% owner) | 2,447,731 | $0 | $0 | 2,447,731 (Indirect) | View |
| 2007-11-13 Purchase |
2007-11-13 1:38 pm | ARYx Therapeutics, Inc. | ARYX | SIMON NICHOLAS J III (Director 10% owner) | 3,281,264 | $0 | $0 | 3,276,862 (Direct Indirect) | View |
| 2007-11-13 Purchase | 2007-11-13 1:37 pm | ARYx Therapeutics, Inc. | ARYX | EVNIN LUKE GALAKATOS NICHOLAS HENNER DENNIS STEINMETZ MICHAEL GADICKE ANSBERT WHEELER KURT (10% owner) | 3,276,862 | $0 | $0 | 3,276,862 (Indirect) | View |
| 2007-11-13 Purchase |
2007-11-13 1:37 pm |
ARYx Therapeutics, Inc. | ARYX | MPM BIOVENTURES III QP LP MPM BIOVENTURES III PARALLEL FUND, LP MPM BIOVENTURES III GMBH & CO. Beteiligungs KG MPM BIOVENTURES III LP MPM BIOVENTURES III GP LP MPM BIOVENTURES III LLC MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC MPM BioVentures Strategic Fund LP (10% owner) | 3,276,862 | $0 | $0 | 3,276,862 (Indirect) |
View |
| Transaction & Date | Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship | Shares Traded | Conversion Price |
Shares Ownership |
Filing |
| 2008-11-14 Purchase |
2009-05-26 4:56 pm | 2008-11-14 2013-11-14 |
ARYx Therapeutics, Inc. | ARYX | ORBIMED ADVISORS LLC ISALY SAMUEL D (10% owner) | 364,395 | $2.64 | 364,395 (Indirect) | View |
| 2009-04-30 Option Award |
2009-05-01 8:29 pm | N/A 2019-04-29 |
ARYx Therapeutics, Inc. | ARYX | SIMON NICHOLAS J III (Director) | 6,666 | $3.8 | 6,666 (Direct) |
View |
| 2009-04-30 Option Award | 2009-05-01 8:26 pm |
N/A 2019-04-29 |
ARYx Therapeutics, Inc. | ARYX | Ekman Lars (Director) | 6,666 | $3.8 | 6,666 (Direct) | View |
| 2009-04-30 Option Award | 2009-05-01 8:23 pm | N/A 2019-04-29 | ARYx Therapeutics, Inc. | ARYX | Leonard Keith R (Director) | 6,666 | $3.8 | 6,666 (Direct) | View |
| 2009-04-30 Option Award | 2009-05-01 8:15 pm | N/A 2019-04-29 | ARYx Therapeutics, Inc. | ARYX | ROSENMAN HERM (Director) | 6,666 | $3.8 | 6,666 (Direct) | View |
| 2009-04-30 Option Award |
2009-05-01 8:06 pm | N/A 2019-04-29 | ARYx Therapeutics, Inc. | ARYX | SEKHRI PAUL J (Director) | 6,666 | $3.8 | 6,666 (Direct) | View |
| 2009-04-30 Option Award |
2009-05-01 8:01 pm | N/A 2019-04-29 | ARYx Therapeutics, Inc. | ARYX | BEIER DAVID W (Director) | 6,666 | $3.8 | 6,666 (Direct) |
View |
| 2009-02-18 Option Award | 2009-02-20 9:22 pm |
N/A 2019-02-17 | ARYx Therapeutics, Inc. | ARYX | Barker Jason (Sr.Dir.& Principal Acctg. Off.) | 9,893 | $2.7 | 9,893 (Direct) |
View |
| 2009-02-18 Option Award | 2009-02-20 9:19 pm | N/A 2019-02-17 |
ARYx Therapeutics, Inc. | ARYX | Canafax Daniel (V.P. & CDO) | 40,000 | $2.7 | 40,000 (Direct) |
View |
| 2009-02-18 Option Award | 2009-02-20 9:11 pm | N/A 2019-02-17 |
ARYx Therapeutics, Inc. | ARYX | Nagler David (V.P.,Corp. Affairs & Sect.) | 60,000 | $2.7 | 60,000 (Direct) | View |
| 2009-02-18 Option Award | 2009-02-20 9:08 pm |
N/A 2019-02-17 |
ARYx Therapeutics, Inc. | ARYX | Druzgala Pascal (Sr. V.P. & Chief Scien.Off.) | 60,000 | $2.7 | 60,000 (Direct) | View |
| 2009-02-18 Option Award |
2009-02-20 9:06 pm | N/A 2019-02-17 | ARYx Therapeutics, Inc. | ARYX | Milner Peter G (Pres., Research & Dev. Director) | 90,000 | $2.7 | 90,000 (Direct) |
View |
| 2009-02-18 Option Award |
2009-02-20 9:03 pm |
N/A 2019-02-17 | ARYx Therapeutics, Inc. | ARYX | Varian John (COO & CFO) | 100,000 | $2.7 | 100,000 (Direct) | View |
| 2009-02-18 Option Award |
2009-02-20 9:00 pm | N/A 2019-02-17 | ARYx Therapeutics, Inc. | ARYX | GODDARD PAUL (Chairman & CEO Director) | 200,000 | $2.7 | 200,000 (Direct) |
View |
| 2008-11-14 Purchase | 2008-11-18 4:39 pm | 2008-11-14 2013-11-14 | ARYx Therapeutics, Inc. | ARYX | Adelman Robert J (Director 10% owner) | 364,395 | $2.64 | 364,395 (Indirect) | View |
| 2008-11-14 Purchase |
2008-11-18 3:10 pm | 2008-11-14 2013-11-14 |
ARYx Therapeutics, Inc. | ARYX | ORBIMED ADVISORS LLC ISALY SAMUEL D (10% owner) | 364,395 | $2.64 | 364,395 (Indirect) |
View |
| 2008-11-14 Purchase |
2008-11-17 7:23 pm |
2008-11-14 2013-11-14 | ARYx Therapeutics, Inc. | ARYX | MPM BIOVENTURES III QP LP MPM BIOVENTURES III PARALLEL FUND, LP MPM BIOVENTURES III GMBH & CO. Beteiligungs KG MPM BIOVENTURES III LP MPM BIOVENTURES III GP LP MPM BIOVENTURES III LLC MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC MPM BioVentures Strategic Fund LP (10% owner) | 536,313 | $2.64 | 536,313 (Indirect) |
View |
| 2008-11-14 Purchase | 2008-11-17 7:18 pm | 2008-11-14 2013-11-14 |
ARYx Therapeutics, Inc. | ARYX | SIMON NICHOLAS J III (Director 10% owner) | 536,313 | $2.64 | 536,313 (Indirect) | View |
| 2008-11-14 Purchase |
2008-11-17 7:15 pm | 2008-11-14 2013-11-14 | ARYx Therapeutics, Inc. | ARYX | EVNIN LUKE GALAKATOS NICHOLAS HENNER DENNIS STEINMETZ MICHAEL GADICKE ANSBERT WHEELER KURT (10% owner) | 536,313 | $2.64 | 536,313 (Indirect) | View |
| 2008-08-28 Option Award |
2008-09-02 4:18 pm | N/A 2018-08-27 | ARYx Therapeutics, Inc. | ARYX | BEIER DAVID W (Director) | 16,666 | $6.33 | 16,666 (Direct) |
View |
| 2008-02-06 Option Award | 2008-02-15 8:25 pm | N/A 2018-02-05 | ARYx Therapeutics, Inc. | ARYX | Barker Jason (Sr.Dir.& Principal Actg.Ofcr.) | 8,833 | $7.55 | 8,833 (Direct) | View |
| 2008-02-06 Option Award | 2008-02-07 9:04 pm | N/A 2018-02-05 |
ARYx Therapeutics, Inc. | ARYX | Nagler David (V.P. Corp. Affairs & Secretary) | 30,000 | $7.55 | 30,000 (Direct) |
View |
| 2008-02-06 Option Award | 2008-02-07 8:59 pm | N/A 2018-02-05 | ARYx Therapeutics, Inc. | ARYX | Canafax Daniel (V.P. & CDO) | 60,000 | $7.55 | 60,000 (Direct) | View |
| 2008-02-06 Option Award |
2008-02-07 8:53 pm | N/A 2018-02-05 |
ARYx Therapeutics, Inc. | ARYX | Druzgala Pascal (V.P. & Chief Scientific Off.) | 35,000 | $7.55 | 35,000 (Direct) | View |
| 2008-02-06 Option Award | 2008-02-07 8:47 pm | N/A 2018-02-05 | ARYx Therapeutics, Inc. | ARYX | Varian John (COO & CFO) | 44,000 | $7.55 | 44,000 (Direct) |
View |
| 2008-02-06 Option Award |
2008-02-07 8:43 pm | N/A 2018-02-05 |
ARYx Therapeutics, Inc. | ARYX | Milner Peter G (Pres., Research & Dev.) | 40,000 | $7.55 | 40,000 (Direct) |
View |
| 2008-02-06 Option Award |
2008-02-07 8:35 pm | N/A 2018-02-05 |
ARYx Therapeutics, Inc. | ARYX | GODDARD PAUL (Chairman & CEO Director) | 100,000 | $7.55 | 100,000 (Direct) | View |
| 2007-11-13 Purchase |
2007-11-15 3:56 pm | N/A N/A | ARYx Therapeutics, Inc. | ARYX | ORBIMED ADVISORS LLC ISALY SAMUEL D (Director) | 897,866 | $0 | 0 (Indirect) |
View |
| 2007-11-13 Purchase |
2007-11-15 3:56 pm |
N/A N/A |
ARYx Therapeutics, Inc. | ARYX | ORBIMED ADVISORS LLC ISALY SAMUEL D (Director) | 604,228 | $0 | 0 (Indirect) | View |
| 2007-11-13 Purchase | 2007-11-15 3:56 pm |
N/A N/A |
ARYx Therapeutics, Inc. | ARYX | ORBIMED ADVISORS LLC ISALY SAMUEL D (Director) | 323,399 | $0 | 0 (Indirect) |
View |
| 2007-11-13 Purchase |
2007-11-14 6:10 pm |
N/A N/A | ARYx Therapeutics, Inc. | ARYX | Milner Peter G (Pres., Research & Dev. Director) | 10,101 | $0 | 0 (Direct) | View |
| 2007-11-13 Purchase | 2007-11-14 6:10 pm |
N/A N/A |
ARYx Therapeutics, Inc. | ARYX | Milner Peter G (Pres., Research & Dev. Director) | 1,683 | $0 | 0 (Direct) |
View |
| 2007-11-13 Purchase | 2007-11-14 6:10 pm | N/A N/A |
ARYx Therapeutics, Inc. | ARYX | Milner Peter G (Pres., Research & Dev. Director) | 416 | $0 | 0 (Indirect) |
View |
| 2007-11-13 Purchase |
2007-11-14 6:10 pm |
N/A N/A | ARYx Therapeutics, Inc. | ARYX | Milner Peter G (Pres., Research & Dev. Director) | 416 | $0 | 0 (Indirect) | View |
| 2007-11-13 Purchase |
2007-11-14 6:10 pm |
N/A N/A |
ARYx Therapeutics, Inc. | ARYX | Milner Peter G (Pres., Research & Dev. Director) | 16,835 | $0 | 0 (Indirect) |
View |
| 2007-11-13 Purchase | 2007-11-14 6:10 pm |
N/A N/A | ARYx Therapeutics, Inc. | ARYX | Milner Peter G (Pres., Research & Dev. Director) | 3,393 | $0 | 0 (Indirect) | View |
| 2007-11-13 Purchase | 2007-11-14 6:10 pm |
N/A N/A | ARYx Therapeutics, Inc. | ARYX | Milner Peter G (Pres., Research & Dev. Director) | 14,409 | $0 | 0 (Indirect) | View |
| 2007-11-13 Purchase |
2007-11-14 6:09 pm |
N/A N/A |
ARYx Therapeutics, Inc. | ARYX | GODDARD PAUL (Chairman & CEO Director) | 3,021 | $0 | 0 (Indirect) | View |
| 2007-11-13 Purchase |
2007-11-14 6:07 pm | N/A N/A |
ARYx Therapeutics, Inc. | ARYX | Adelman Robert J (Director 10% owner) | 897,866 | $0 | 0 (Indirect) | View |
| 2007-11-13 Purchase |
2007-11-14 6:07 pm | N/A N/A | ARYx Therapeutics, Inc. | ARYX | Adelman Robert J (Director 10% owner) | 604,228 | $0 | 0 (Indirect) | View |
| 2007-11-13 Purchase | 2007-11-14 6:07 pm |
N/A N/A |
ARYx Therapeutics, Inc. | ARYX | Adelman Robert J (Director 10% owner) | 323,399 | $0 | 0 (Indirect) |
View |
| 2007-11-13 Purchase | 2007-11-14 6:05 pm | N/A N/A |
ARYx Therapeutics, Inc. | ARYX | Druzgala Pascal (V.P. & Chief Scientific Off.) | 1,122 | $0 | 0 (Direct) | View |
| 2007-11-13 Purchase | 2007-11-13 6:59 pm |
N/A N/A |
ARYx Therapeutics, Inc. | ARYX | Nomura Phase4 Ventures LTD Nomura Phase4 Ventures LP (10% owner) | 2,014,098 | $0 | 0 (Indirect) | View |
| 2007-11-13 Purchase |
2007-11-13 6:59 pm | N/A N/A | ARYx Therapeutics, Inc. | ARYX | Nomura Phase4 Ventures LTD Nomura Phase4 Ventures LP (10% owner) | 433,633 | $0 | 0 (Indirect) |
View |
| 2007-11-13 Purchase | 2007-11-13 1:38 pm |
N/A N/A | ARYx Therapeutics, Inc. | ARYX | SIMON NICHOLAS J III (Director 10% owner) | 2,777 | $0 | 0 (Direct) | View |
| 2007-11-13 Purchase | 2007-11-13 1:38 pm |
N/A N/A | ARYx Therapeutics, Inc. | ARYX | SIMON NICHOLAS J III (Director 10% owner) | 1,571,267 | $0 | 0 (Indirect) | View |
| 2007-11-13 Purchase |
2007-11-13 1:38 pm | N/A N/A | ARYx Therapeutics, Inc. | ARYX | SIMON NICHOLAS J III (Director 10% owner) | 1,125,077 | $0 | 0 (Indirect) |
View |
| 2007-11-13 Purchase | 2007-11-13 1:38 pm |
N/A N/A | ARYx Therapeutics, Inc. | ARYX | SIMON NICHOLAS J III (Director 10% owner) | 580,518 | $0 | 0 (Indirect) |
View |
| 2007-11-13 Purchase |
2007-11-13 1:37 pm |
N/A N/A | ARYx Therapeutics, Inc. | ARYX | EVNIN LUKE GALAKATOS NICHOLAS HENNER DENNIS STEINMETZ MICHAEL GADICKE ANSBERT WHEELER KURT (10% owner) | 1,571,267 | $0 | 0 (Indirect) |
View |
| 2007-11-13 Purchase | 2007-11-13 1:37 pm | N/A N/A | ARYx Therapeutics, Inc. | ARYX | EVNIN LUKE GALAKATOS NICHOLAS HENNER DENNIS STEINMETZ MICHAEL GADICKE ANSBERT WHEELER KURT (10% owner) | 1,125,077 | $0 | 0 (Indirect) | View |
| 2007-11-13 Purchase | 2007-11-13 1:37 pm |
N/A N/A |
ARYx Therapeutics, Inc. | ARYX | EVNIN LUKE GALAKATOS NICHOLAS HENNER DENNIS STEINMETZ MICHAEL GADICKE ANSBERT WHEELER KURT (10% owner) | 580,518 | $0 | 0 (Indirect) |
View |
| 2007-11-13 Purchase |
2007-11-13 1:37 pm |
N/A N/A | ARYx Therapeutics, Inc. | ARYX | MPM BIOVENTURES III QP LP MPM BIOVENTURES III PARALLEL FUND, LP MPM BIOVENTURES III GMBH & CO. Beteiligungs KG MPM BIOVENTURES III LP MPM BIOVENTURES III GP LP MPM BIOVENTURES III LLC MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC MPM BioVentures Strategic Fund LP (10% owner) | 1,571,267 | $0 | 0 (Indirect) |
View |
| 2007-11-13 Purchase |
2007-11-13 1:37 pm | N/A N/A |
ARYx Therapeutics, Inc. | ARYX | MPM BIOVENTURES III QP LP MPM BIOVENTURES III PARALLEL FUND, LP MPM BIOVENTURES III GMBH & CO. Beteiligungs KG MPM BIOVENTURES III LP MPM BIOVENTURES III GP LP MPM BIOVENTURES III LLC MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC MPM BioVentures Strategic Fund LP (10% owner) | 1,125,077 | $0 | 0 (Indirect) | View |
| 2007-11-13 Purchase | 2007-11-13 1:37 pm |
N/A N/A |
ARYx Therapeutics, Inc. | ARYX | MPM BIOVENTURES III QP LP MPM BIOVENTURES III PARALLEL FUND, LP MPM BIOVENTURES III GMBH & CO. Beteiligungs KG MPM BIOVENTURES III LP MPM BIOVENTURES III GP LP MPM BIOVENTURES III LLC MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC MPM BioVentures Strategic Fund LP (10% owner) | 580,518 | $0 | 0 (Indirect) | View |
| 2007-11-07 Option Award | 2007-11-09 6:02 pm |
N/A 2017-11-07 | ARYx Therapeutics, Inc. | ARYX | SIMON NICHOLAS J III (Director) | 16,666 | $8.1 | 16,666 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 23:16:33 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |